Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

INTRODUCTION: The PRONTO-T1D study, which evaluated the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes (T1D), met the primary endpoint of noninferiority of HbA1c change from baseline compared to lispro at 26 weeks. We present results of an additional 26...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Ther
Glavni autori: Bue-Valleskey, Juliana, Klaff, Leslie, Cho, Jang Ik, Dellva, Mary Anne, Schloot, Nanette C., Tobian, Janet, Miura, Junnosuke, Dahl, Dominik
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7846637/
https://ncbi.nlm.nih.gov/pubmed/33458803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00987-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items